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Abstract
Background: Chronic osteomyelitis is a challenging problem, and malignant transformation is a rare occurrence.
We report a case of a patient with squamous cell carcinoma arising from an osteomyelitic hotbed and discuss
through a literature review the etiopathogenesis, diagnosis, and treatment of this lesion.
Case presentation: A 69-year-old Italian man had sustained an exposed tibial fracture 40 years ago during a road
accident, for which he had undergone various surgical osteosynthesis treatments with multiple antibiotic therapies.
He presented to our hospital because of recurrence of a fistula at the proximal third of the anterior region of the tibia.
For 2 months, we treated the lesion with antibiotics, and local medication with curettage. We saw no evidence of
lesion improvement, and we advised the patient to undergo a knee amputation, which he refused. The alternative
we chose was a surgical toilet of the osteomyelitic hotbed and used bioglass as a bone substitute. After 2 months of
follow-up, we noticed a fulminating, budding formation in the area of the surgical wound that turned out to be a
squamous cell carcinoma on biopsy. The patient again refused the amputation and underwent a wide-margin surgical
debridement. After 2 months, the carcinoma recurred, and an above-the-knee amputation was performed.
Conclusions: Our experience with this case indicates that amputation is the most appropriate treatment for squamous
carcinoma occurring in patients with chronic osteomyelitis. To avoid risks of lymphonodular and organ metastasization,
this radical surgical procedure should not be delayed. Early diagnosis and timely therapy can prevent amputation only
in selected cases. Surgeons who treat osteomyelitis and chronic wounds should be aware of the risk of tumor
degeneration. Squamous cell carcinoma associated with chronic osteomyelitis has a low-grade malignancy,
but implications of lymphonodular involvement and organ metastasis should not be excluded.
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Background
Chronic osteomyelitis is considered a great challenge
for the orthopedist. The characteristic bone histology
and the ability of bacteria to adapt to this particular
microenvironment make these infections among the
most insidious in the human body. Osteomyelitis is
an inflammation involving the osteoarticular apparatus
and its medullary canal that evolves in a progressive
destruction of bone tissue. The characteristics of this
phenomenon are bacterial colonies organized and
protected by biofilm, a polymeric matrix the colonies
excrete, often a polysaccharide. It is hard to breach
this barrier, and antibiotics and disinfectants do their
best to kill these shielded bacterial colonies. Further-
more, bacterial colonies enter a semidormant state
that stretches pharmacodynamic effects of chemother-
apies and the immune system, both specific and non-
specific. In this report, we present a case of recurrent
squamous cell carcinoma in a patient with chronic
osteomyelitis for which surgical amputation of the
limb was initially avoided.
Case presentation
A 69-year-old Italian man came to our hospital for treat-
ment of a 5-mm fistula at the proximal third of the
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anterior region of the tibia. He was affected by chronic
osteomyelitis because of an exposed fracture that had
occurred 40 years ago. Plain x-rays showed an osteolytic
area above the wound (Fig. 1). In the first years following
the trauma, he had undergone many osteosynthesis sur-
gical interventions and antibiotic regimens. The patient
was self-sufficient, in good clinical condition, and had
no comorbidities. The neurovascular status of his
affected leg was intact. In 1994, he had undergone a bi-
lateral inguinal herniotomy, and in 2000 he had had a
hemorrhoidectomy. He contracted hepatitis C virus dur-
ing his first hospitalization after the trauma.
Scintigraphy confirmed the presence of an intraoss-
eous infective process in the involved region (Fig. 2). A
swab culture of the fistula was positive for Bacteroides
fragilis and Corynebacterium striatum, so the patient
underwent therapy with metronidazole (500 mg by
mouth every 6 h). After 30 days, the fistula had in-
creased in size, and fibrotic tissue, perilesional erythema,
and malodor were present. We recommended to the pa-
tient that he undergo amputation of the knee, a treat-
ment that he refused. Therefore, he underwent a
surgical toilet of the osteomyelitic hotbed, and inflam-
matory tissue and macerated bone were removed. The
bone defect was treated with bioglass (Fig. 3). The surgical
wound was closed without any skin grafting. The result of
an intrasurgical swab culture was positive for Pseudo-
monas aeruginosa. We started the patient on a multiple-
antibiotic regimen with amikacin (500 mg intravenously
every 12 h), meropenem (2 g intravenously every 8 h), and
ciprofloxacin (500 mg by mouth every 12 h). After 2
months of inpatient care, a fulminating budding formation
was observed on the wound margins. A biopsy revealed
that it was a squamous cell carcinoma (Fig. 4). The patient
underwent whole-body computed tomography (CT),
which revealed bone lesions and soft tissue masses. His
neoplasia turned out to be T3N0M0; according to the
American Cancer Society guidelines, it was at stage III [1].
He underwent a wide-margin surgical debridement and
bioglass removal (Figs. 5 and 6). After 2 months, the ma-
lignant lesion recurred locally (Fig. 7), and we performed a
below-the-knee amputation.
Discussion
Neoplasms as a result of chronic insults were de-
scribed as early as during the Roman Empire. Aulus
Cornelius Celsius told of tumoral neoformations in
correspondence to chronic wounds [2]. During the
mid-19th century, Hawkins and Marjolin correlated
these skin diseases with osteomyelitis [3]. In a Mayo
Clinic study in which investigators analyzed about
4000 cases of chronic osteomyelitis, malignant lesions
were noted in 23 % of the patients [4]. The incidence
of skin lesions ranges between 0.2 % and 1.7 % of all
patients affected by osteomyelitis [5, 6]. In developing
countries, the percentages increase with delayed diag-
nosis and inadequate treatments [7]. Nowadays,
trauma is the most common cause of osteomyelitis
[5]: Infection rates range from 4 % to 64 % in open
long bone fractures, and the incidence is increasing
[8]. The occurrence of hematogenous osteomyelitis is
declining, with the incidence dropping from 87 to 42
cases per 10,000 [8]. The duration of osteomyelitis
appears to be the principal factor related to carcino-
genesis onset, with a minimum latency period of 20
years or more [9]. Males are affected more often than
women, with a predominance of 85 %, and patients’
are typically aged between 50 and 60 years old [5].
The tibia, femur, and foot are the most frequent
locations [5, 10]. Clinical signs that should alert the
Fig. 1 Anteroposterior (a) and lateral (b) x-rays of the tibia showing an area of inhomogeneous osteostructural depletion at the proximal third
of the tibia
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clinician about malignant transformation include in-
creased pain, blood, or foul release from the sinus;
progressive bone destruction and erosion; and a grow-
ing mass in the area of the wound [2]. To prevent
local invasion and metastatic spread, treatment should
not be delayed. The pathogenesis of this neoformation
is still under debate, but the most widely accepted
theory is focused on the chronic inflammatory state
[7, 11]. In these conditions, the immune system is
dysregulated: Inflammatory mediators and cytokines
expressed by the immune system modulate the genic
expression of various proteins, including p53 [11].
Furthermore, avascular areas and lymphatic duct ob-
literation [7] are conditions that discourage antigen
presentation. Polymicrobial infection sites are also
characterized by horizontal gene transfer and consequent
latent mutations that interfere with the immune response
[12]. There is evidence that carcinomatous transform-
ation can follow a shift in bacterial flora. Gram-
positive flora can be replaced by predominant gram-
negative flora that produce endotoxins associated with
cancer [12].
Squamous cell carcinoma is characterized by an intrae-
pidermal proliferation of atypical keratinocytes [13],
Fig. 3 Anteroposterior (a) and lateral (b) x-rays obtained after the first surgical intervention, in which bioglass was applied
Fig. 2 Scintigraphic (a and b) of the tibia presenting a polylobed area with an increased distribution of radiocytes in the proximal third of the
tibia that involves both the bone and the soft tissues
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when associated with chronic osteomyelitis is usually of
low grade malignancy [14].
The diagnosis can be made with the use of a primary
and secondary imaging medical device. Magnetic reson-
ance imaging can be useful to differentiate squamous cell
carcinoma from other soft tissue neoplasms [15]. Whole-
body positron emission tomography-CT can clarify a
suspicion of metastasis, especially in the lungs, the most
common site. Shave biopsy, incisional biopsy, excisional
biopsy, and punch biopsy are the settling examinations
[14]. They should include portions of the entire lesion:
ulcer, sinus, and the marrow space.
Patients affected by chronic osteomyelitis with
recurrent exacerbations undergo frequent hospital
admissions, pharmacological therapies, and surgical
procedures during their lifetimes. Several authors have
suggested that amputation is the definitive treatment
[5, 10, 16, 17]. Body image anxiety, social discomfort,
and depression are frequent consequences of lower
limb amputation [18, 19]. It is a tough choice that in-
volves both physical and psychological issues, but in
our experience it can guarantee better quality of life.
In some selected cases and in the absence of metasta-
sis, it is possible to evaluate a wide excision of the
lesion, making use of Mohs micrographic surgery to
resect at least 2 cm of tumor-free margins. Our
patient at first did not accept the amputation. In his
opinion, it would have prevented him from riding
motorbikes, his preferred sport activity, and it would
have altered his social role. Different authors have
reported that persons with lower limb amputation can
restore patients’ life habits [19] and riding and/or
Fig. 5 Clinical photography of the wound after wide-margin surgical debridement and bioglass removal
Fig. 4 Clinical photography of the wound 2 months after the first surgical intervention, showing the squamous cell carcinoma
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driving capabilities [20], but barriers such as family
understanding, inadequate legislation, and confusion
over various driving adaptations can slow the return
to the community [19] and to the activities conducted
before the amputation [20]. Our patient underwent a
toilet of the osteomyelitic hotbed. The bone substitute
we used is BonAlive S53P4 bioglass (BonAlive Bioma-
terials, Turku, Finland). Bone graft substitutes are
widely used in orthopaedics since several decades
with good outcomes whenever there is a need of a
matrix capable to bridge regenerative or reparative
biological effects. In most cases bone substitutes have
just an osteoconductive effect and their efficacy is re-
stricted only to certain conditions [21, 22]. Autolo-
gous or heterologous bone transplants, in addition to
being a substitute, have an osteostimulative effect.
Unfortunately, the autologous effects are related to
the adverse effects and comorbidities associated with
a second surgical procedure, while the heterologous
effects are related to infective risks and immune in-
tolerance. Bioglass is a material with both osteo-
conductive and osteostimulative effects, as well as having
antibacterial properties [21, 22].
Conclusions
Malignant transformation in chronic osteomyelitis is a
rare but unfavorable condition. Early diagnosis on the
basis of information related to both clinical signs and
imaging can lead to less invasive surgical treatments.
Amputation is the definitive treatment of recurrent
chronic osteomyelitis even in the absence of neoplastic
transformation. It should not be delayed, and the pa-
tient’s compliance is of prime importance. Surgeons
should be aware of the risk of tumor degeneration in
patients with osteomyelitis and chronic wounds.
Fig. 7 Clinical photography of the tibia demonstrating the
squamous cell carcinoma recurrence
Fig. 6 Anteroposterior (a) and lateral (b) x-ray demonstrating the bone depletion after the second surgical procedure
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Abbreviation
CT, computed tomography
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